ABBOTT LABORATORIES ABT

Latest FY: 2025 Healthcare Medical Devices
Market Price $103.36
Market Cap $180.03B
P/E Ratio 27.78
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑5.7% YoY
$44.33B
3-Yr CAGR: 0.5%
Net Income ↓-51.3% YoY
$6.52B
Net Margin: 14.7%
Free Cash Flow ↑16.4% YoY
$7.39B
FCF Yield: 4.11%
EPS (Diluted) ↓-51.3% YoY
$3.72
Basic: $3.73
Return on Equity Efficiency
12.5%
ROA: 7.5%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (ABT)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $20,853.0M $11,829.0M $1,400.0M $0.94 $1.04 2.71% $3,203.0M $2,082.0M
FY 2017 $27,390.0M +31.3% $15,053.0M $477.0M -65.9% $0.27 -71.3% $1.06 1.86% $5,570.0M $4,435.0M +113.0%
FY 2018 $30,578.0M +11.6% $17,872.0M $2,368.0M +396.4% $1.33 +392.6% $1.12 1.54% $6,300.0M $4,906.0M +10.6%
FY 2019 $31,904.0M +4.3% $18,673.0M $3,687.0M +55.7% $2.06 +54.9% $1.27 1.47% $6,136.0M $4,498.0M -8.3%
FY 2020 $34,608.0M +8.5% $19,605.0M $4,495.0M +21.9% $2.50 +21.4% $1.43 1.31% $7,901.0M $5,724.0M +27.3%
FY 2021 $43,075.0M +24.5% $24,538.0M $7,071.0M +57.3% $3.94 +57.6% $1.79 1.27% $10,533.0M $8,648.0M +51.1%
FY 2022 $43,653.0M +1.3% $24,511.0M $6,933.0M -2.0% $3.91 -0.8% $1.88 1.71% $9,581.0M $7,804.0M -9.8%
FY 2023 $40,109.0M -8.1% $22,134.0M $5,723.0M -17.5% $3.26 -16.6% $2.03 1.85% $7,261.0M $5,059.0M -35.2%
FY 2024 $41,950.0M +4.6% $23,244.0M $13,402.0M +134.2% $7.64 +134.4% $2.24 1.98% $8,558.0M $6,351.0M +25.5%
FY 2025 $44,328.0M +5.7% $25,009.0M $6,524.0M -51.3% $3.72 -51.3% $2.40 1.92% $9,566.0M $7,395.0M +16.4%
$

Valuation

Market Price $103.36
Market Cap $180.03B
Enterprise Value $184.44B
P/E Ratio 27.78
P/B Ratio 3.45
FCF Yield 4.11%
Dividend Yield 2.32%
Shares Outstanding 1,741,813,200
%

Profitability & Margins

Gross Margin 56.42%
Operating Margin 18.17%
Net Margin 14.72%
Return on Equity (ROE) 12.51%
Return on Assets (ROA) 7.52%
Asset Turnover 0.51x
Revenue 3-Yr CAGR 0.51%
🛡️

Financial Health & Liquidity

Current Ratio 1.58
Cash Ratio 0.52
Debt / Equity 0.248
Debt / Assets 0.149
Cash & Equivalents $8.52B
Total Debt $12.93B
Book Value / Share $29.93
💧

Cash Flow Efficiency

Operating Cash Flow $9.57B
Capital Expenditures (CapEx) $2.17B
Free Cash Flow $7.39B
OCF / Revenue 21.58%
FCF / Revenue 16.68%
FCF 3-Yr CAGR -1.78%
🏷️

Per Share Metrics

EPS (Diluted) $3.72
EPS (Basic) $3.73
Dividends / Share $2.40
Book Value / Share $29.93
EPS YoY Growth -51.31%
🏛️

Balance Sheet (FY 2025)

Total Assets $86.71B
Total Liabilities $34.58B
Stockholders' Equity $52.13B
Current Assets $26.00B
Current Liabilities $16.50B